54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
00:32 UTC
|
CRCL
Circle Internet Group
|
◎ Target | James Faucette ★★★☆☆ #1134 | Underweight | $38.00→ $37.00-2.6% |
|
Aug 07
00:32 UTC
|
CPRI
Capri
|
◎ Target | Adrienne Yih ★★★☆☆ #1564 | Overweight | $20.00→ $19.00-5.0% |
|
Aug 07
00:32 UTC
|
CPRI
Capri
|
◎ Target | Jay Sole ★★★☆☆ #1505 | Neutral | $20.00→ $17.00-15.0% |
|
Aug 07
00:32 UTC
|
CPRI
Capri
|
◎ Target | Brooke Roach ★★★☆☆ #1920 | Neutral | $21.00→ $18.00-14.3% |
|
Aug 07
00:32 UTC
|
CPRI
Capri
|
◎ Target | Robert Drbul ★★★★☆ #770 | Buy | $30.00→ $25.00-16.7% |
|
Aug 07
00:32 UTC
|
CPRI
Capri
|
◎ Target | Dana Telsey ★★★☆☆ #991 | Market Perform | $21.00→ $18.00-14.3% |
|
Aug 07
00:32 UTC
|
CPAY
Corpay
|
◎ Target | Sanjay Sakhrani ★★★☆☆ #1368 | Outperform | $400.00→ $470.00+17.5% |
|
Aug 07
00:32 UTC
|
CPAY
Corpay
|
◎ Target | Tien-Tsin Huang not yet tracked | Overweight | $400.00→ $470.00+17.5% |
|
Aug 07
00:32 UTC
|
CPAY
Corpay
|
◎ Target | Daniel Perlin ★★★★☆ #380 | Sec→ r Perform | $363.00→ $423.00+16.5% |
|
Aug 07
00:32 UTC
|
CPAY
Corpay
|
◎ Target | Roger Boyd ★★★★★ #72 | Neutral | $385.00→ $415.00+7.8% |
|
Aug 07
00:32 UTC
|
COR
Cencora
|
◎ Target | Kevin Caliendo ★★★★☆ #545 | Buy | $412.00→ $430.00+4.4% |
|
Aug 07
00:32 UTC
|
COOK
Traeger
|
◎ Target | Joseph Feldman not yet tracked | Market Perform | $45.00→ $65.00+44.4% |
|
Aug 07
00:32 UTC
|
COLL
Collegium Pharmaceutical
|
◎ Target | Serge Belanger ★★★☆☆ #1891 | Buy | $56.00→ $46.00-17.9% |
|
Aug 07
00:32 UTC
|
CMPS
Compass Pathways
|
◎ Target | Leonid Timashev ★★★☆☆ #1391 | Outperform | $22.00→ $21.00-4.5% |
|
Aug 07
00:32 UTC
|
CMPS
Compass Pathways
|
◎ Target | Judah Frommer ★★★☆☆ #1634 | Overweight | $17.00→ $18.00+5.9% |
|
Aug 07
00:32 UTC
|
CMPS
Compass Pathways
|
◎ Target | Madison El-Saadi not yet tracked | Buy | $17.00→ $22.00+29.4% |
|
Aug 07
00:32 UTC
|
CMC
Commercial Metals
|
◎ Target | Katja Jancic ★★★☆☆ #2099 | Market Perform | $77.00→ $80.00+3.9% |
|
Aug 07
00:32 UTC
|
CLOV
Clover Health Investments
|
◎ Target | Jonathan Yong ★☆☆☆☆ #3004 | Neutral | $4.75→ $5.00+5.3% |
|
Aug 07
00:32 UTC
|
CLFD
Clearfield
|
◎ Target | Ryan Koontz ★☆☆☆☆ #3105 | Buy | $52.00→ $40.00-23.1% |
|
Aug 07
00:32 UTC
|
CLBT
Cellebrite DI
|
◎ Target | Rudy Kessinger ★★★★★ #159 | Buy | $20.00→ $22.00+10.0% |
|
Aug 07
00:32 UTC
|
CIM
Chimera Investment
|
◎ Target | Bose George ★★★☆☆ #2153 | Market Perform | $15.00→ $14.00-6.7% |
|
Aug 07
00:32 UTC
|
CIFR
Cipher Mining
|
◎ Target | Stephen Glagola ★☆☆☆☆ #3121 | Outperform | $32.00→ $28.00-12.5% |
|
Aug 07
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | Timothy Chiodo ★★★★★ #254 | Neutral | $26.00→ $28.00+7.7% |
|
Aug 07
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | Joseph Vafi ★☆☆☆☆ #3118 | Buy | $40.00→ $45.00+12.5% |
|
Aug 07
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | Will Nance ★★★★☆ #920 | Buy | $26.00→ $33.00+26.9% |
|
Aug 07
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | Hal Goetsch ★★☆☆☆ #2407 | Buy | $35.00→ $37.00+5.7% |
|
Aug 07
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | Andrew Bauch ★★★★☆ #567 | Outperform | $28.00→ $32.00+14.3% |
|
Aug 07
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | Sanjay Sakhrani ★★★☆☆ #1368 | Outperform | $30.00→ $35.00+16.7% |
|
Aug 07
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | James Faucette ★★★☆☆ #1134 | Overweight | $31.00→ $33.00+6.5% |
|
Aug 07
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | Patrick Moley ★★★☆☆ #1855 | Overweight | $30.00→ $35.00+16.7% |
|
Aug 07
00:32 UTC
|
CHR
Chorus Aviation
|
◎ Target | firm only | Buy | C$33.00→ C$34.00+3.0% |
|
Aug 07
00:32 UTC
|
CHR
Chorus Aviation
|
◎ Target | firm only | Outperform | C$28.00→ C$32.00+14.3% |
|
Aug 07
00:32 UTC
|
CHR
Chorus Aviation
|
◎ Target | firm only | Outperform | C$35.00→ C$39.00+11.4% |
|
Aug 07
00:32 UTC
|
CHR
Chorus Aviation
|
◎ Target | firm only | Sec→ r Outperform | C$31.00→ C$33.50+8.1% |
|
Aug 07
00:32 UTC
|
CHR
Chorus Aviation
|
◎ Target | firm only | Buy | C$32.00→ C$33.00+3.1% |
|
Aug 07
00:32 UTC
|
CHH
Choice Hotels International
|
◎ Target | Brandt Montour ★★★☆☆ #1506 | Underweight | $101.00→ $102.00+1.0% |
|
Aug 07
00:32 UTC
|
CHCT
Community Healthcare Trust
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1105 | Neutral | $20.00→ $17.00-15.0% |
|
Aug 07
00:32 UTC
|
CG
Carlyle Group
|
◎ Target | Devin Ryan ★★★☆☆ #2044 | Market Outperform | $70.00→ $73.00+4.3% |
|
Aug 07
00:32 UTC
|
CG
Carlyle Group
|
◎ Target | Kyle Voigt ★★☆☆☆ #2540 | Market Perform | $47.00→ $50.00+6.4% |
|
Aug 07
00:32 UTC
|
CG
Carlyle Group
|
◎ Target | Benjamin Budish ★★★★☆ #729 | Overweight | $57.00→ $64.00+12.3% |
|
Aug 07
00:32 UTC
|
CG
Carlyle Group
|
◎ Target | Michael Brown ★★★★☆ #466 | Buy | $63.00→ $70.00+11.1% |
|
Aug 07
00:32 UTC
|
CE
Celanese
|
◎ Target | Michael Sison ★★★☆☆ #2197 | Overweight | $80.00→ $65.00-18.8% |
|
Aug 07
00:32 UTC
|
CDW
CDW
|
◎ Target | Erik Woodring ★★★☆☆ #1523 | Overweight | $170.00→ $171.00+0.6% |
|
Aug 07
00:32 UTC
|
CDNA
CareDx
|
◎ Target | Mark Massaro ★★★★★ #173 | Buy | $45.00→ $60.00+33.3% |
|
Aug 07
00:32 UTC
|
CCH
Coca-Cola HBC
|
◎ Target | firm only | Buy | GBX 5,550→ GBX 5,700+2.7% |
|
Aug 07
00:32 UTC
|
CCH
Coca-Cola HBC
|
◎ Target | firm only | Buy | GBX 5,007→ GBX 5,453+8.9% |
|
Aug 07
00:32 UTC
|
CCEP
Coca-Cola Europacific Partners
|
◎ Target | Lauren Lieberman ★★★☆☆ #1020 | Overweight | $114.00→ $119.00+4.4% |
|
Aug 07
00:32 UTC
|
CC
Chemours
|
◎ Target | Peter Osterland not yet tracked | Buy | $30.00→ $24.00-20.0% |
|
Aug 07
00:32 UTC
|
CC
Chemours
|
◎ Target | Arun Viswanathan ★★★☆☆ #1251 | Outperform | $26.00→ $22.00-15.4% |
|
Aug 07
00:32 UTC
|
CAVA
CAVA Group
|
◎ Target | Logan Reich ★★★★☆ #970 | Outperform | $105.00→ $90.00-14.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.